i’ve been on tirzepatide for about 14 months now, and i’m still trying to figure out why some people seem to get a slow start with it. i was one of the lucky ones, i guess - my appetite quieted down pretty quickly. but i’ve been reading posts from others who didn’t see much of a difference for months.
is it just about individual metabolism, or is there something else going on? i’ve been wondering if it has to do with the gut slowdown that some people experience - does that affect how quickly the medication kicks in? or is it more about the dosage, or the timing of the injections?
i’d love to hear from others who had a slow start - what was your experience like, and did you notice anything that seemed to speed things up?
that “didn’t see much of a difference for months” is often a function of the titration schedule itself, not a slow individual response. the initial ramp doses are mostly for tolerability, not where the full metabolic effect is expected, so it’s more about the protocol’s pace than a true “slow start” of the drug’s mechanism.
Thinking about why some people feel they have a “slow start” often depends on what signals you’re watching for. For me, as someone with T2D, my CGM picked up hepatic glucose improvement in weeks 4-8, well before I felt significant changes in appetite or saw much shift on the scale.
The assumption that the medication “kicks in” only when hunger goes away often skips over what’s actually happening physiologically at lower doses, especially since appetite suppression at 2.5mg isn’t the primary therapeutic event for T2D anyway. It’s easy to focus on that subjective feeling, but GLP-1 receptor agonism improves hepatic glucose output before appetite suppression is even perceptible for a lot of people.
I logged my CGM readings alongside GI symptoms from day one, and being able to add specific notes to those entries helped separate the motility shifts from the actual glycemic changes, which moved much earlier for me.
when people say they didn’t see much of a difference for months, what did ‘difference’ actually mean for them? was it just appetite, or were they also tracking metabolic labs like A1C or insulin resistance?
when you talk about a slow start, it’s worth separating a few things that often get bundled together, bc they run on different clocks. the pharmacokinetic part - how long it takes for the drug to reach steady state in your system - that’s one timeline. then there’s the GI tolerance clock, which is about how